DSM B.V.
Hieronder vindt u informatie uit het register openbaarmaking voorwetenschap. Deze informatie is door de organisatie verstrekt.
Publicatie datum
17 dec 2010 - 07:22
Statutaire naam
DSM B.V.
Titel
DSM announces reversal of impairment
Bericht
Royal DSM N.V., the global Life Sciences and Materials Sciences company headquartered in the Netherlands, today announces that - in accordance with applicable IFRS accounting standards - the remaining impairment of approximately € 55 million for DSM Anti-Infectives will be reversed in Q4 2010. This reversal of impairment will be reported as an exceptional item in DSM's Q4 2010 results, which will be published on 23 February 2011.
Gerelateerde downloads
Datum laatste update: 28 maart 2025